Bharat Fake News: Govt rejects fake news reports that regulatory approval for Covaxin rushed due to Political Pressure
Bharat CEPI partners with Bharat Biotech, University of Sydney, ExcellGene to develop ‘variant-proof’ COVID-19 vaccine
Bharat Bharat Biotech seeks DCGI’s permission to conduct Covaxin booster trials in the 2-18 age group